论文部分内容阅读
目的:探究米非司酮配伍米索前列醇行药物流产的安全性。方法:选取我院2014年3月-2015年3月120例要求终止妊娠患者,将其按照治疗方法分为实验组以及对照组。实验组给予米非司酮配伍米索前列醇进行药物流产,对照组给予负压吸引流产。对2组终止妊娠患者经不同方法治疗后的效果以及安全性比较分析。结果:2组患者在治疗效果方面不存在明显差异(P>0.05)。实验组不良反应发生率小于对照组(P<0.05)。结论:给予终止妊娠患者米非司酮配伍米索前列醇药流,其效果较好,且不良反应发生率较低,值得临床广泛推广应用。
Objective: To investigate the safety of mifepristone and misoprostol in medical abortion. Methods: A total of 120 cases requiring termination of pregnancy in our hospital from March 2014 to March 2015 were selected and divided into experimental group and control group according to the method of treatment. The experimental group was given mifepristone with misoprostol for medical abortion, while the control group was given negative pressure to induce abortion. Two groups of patients after termination of pregnancy by different methods of treatment efficacy and safety analysis. Results: There was no significant difference in the therapeutic effect between the two groups (P> 0.05). The incidence of adverse reactions in the experimental group was less than that in the control group (P <0.05). Conclusion: Mifepristone combined with misoprostol abortion in patients with termination of pregnancy has good effect and low incidence of adverse reactions, which deserves wide application in clinic.